Latest1 information on COVID-19
©2022 Stanford Medicine
Not Recruiting
Trial ID: NCT01326364
Prognostic Value of Baseline CT Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection
Associate Professor of Surgery (General Surgery)
Professor of Surgery (General Surgery) at the Stanford University Medical Center
Colleen Haas Chair in the School of Medicine
Professor of Radiology (Cardiovascular Imaging)
Inclusion Criteria:
1. suspected and/or biopsy-proven pancreatic adenocarcinoma, and
2. referral to Radiology for pre-treatment baseline pancreatic protocol CT.
Exclusion criteria:
1) are absolute contraindications to intravenous iodinated contrast or CT scan.
procedure: Stereotactic body radiotherapy
drug: Iodixanol
drug: Iohexol
Not Recruiting
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
ccto-office@stanford.edu
650-498-7061